Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis.

Details

Serval ID
serval:BIB_E30535E38867
Type
Article: article from journal or magazin.
Collection
Publications
Title
Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis.
Journal
Archives of disease in childhood. Fetal and neonatal edition
Author(s)
Gerull R., Brauer V., Bassler D., Laubscher B., Pfister R.E., Nelle M., Müller B., Gerth-Kahlert C., Adams M.
Working group(s)
Swiss Neonatal Network & Follow-up Group
ISSN
1468-2052 (Electronic)
ISSN-L
1359-2998
Publication state
Published
Issued date
15/09/2017
Peer-reviewed
Oui
Language
english
Notes
Publication types: Journal Article
Publication Status: aheadofprint
Abstract
Retinopathy of prematurity (ROP) is a severe complication of preterm birth and can lead to severe visual impairment or even blindness if untreated. The incidence of ROP requiring treatment is increasing in some developed countries in conjunction with higher survival rates at the lower end of gestational age (GA).
The incidence of ROP and severe ROP (sROP) requiring treatment in Switzerland was analysed using the SwissNeoNet registry. We conducted a retrospective cohort analysis of very preterm infants with a GA below 32 weeks who were born between 2006 and 2015 in Switzerland. Patient characteristics were stratified according to GA.
9.3% and 1.8% of very preterm infants in Switzerland developed ROP of any stage and sROP, respectively. The incidence of ROP treatment was 1.2%. Patients with 24 and 25 weeks GA had the highest proportion of ROP treatment at 14.5% and 7.3%, respectively, whereas the proportion of treated infants at or above a GA of 29 weeks was 0.06%. Similarly, the risk of sROP declined strongly with increasing GA. During the observation period of 10 years, the incidence of ROP treatment ranged between 0.8% and 2.0%. Incidences of sROP or ROP treatment did not increase over time.
The incidence of ROP treatment in Switzerland is low and was stable over the analysed period. The low incidence of sROP in patients with a GA of 29 weeks or more leaves room for a redefinition of ROP screening criteria.
Keywords
epidemiology, neonatology, ophthalmology
Pubmed
Create date
13/10/2017 16:15
Last modification date
16/07/2020 9:43
Usage data